Viewing Study NCT01864902


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2026-03-13 @ 2:30 PM
Study NCT ID: NCT01864902
Status: UNKNOWN
Last Update Posted: 2016-01-28
First Post: 2013-05-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33
Sponsor: Chinese PLA General Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-04
Start Date Type: None
Primary Completion Date: 2016-04
Primary Completion Date Type: ESTIMATED
Completion Date: 2017-04
Completion Date Type: ESTIMATED
First Submit Date: 2013-05-20
First Submit QC Date: None
Study First Post Date: 2013-05-30
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-01-26
Last Update Post Date: 2016-01-28
Last Update Post Date Type: ESTIMATED